These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27627627)

  • 1. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
    Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
    ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
    Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ
    PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
    Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
    Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
    Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis.
    Lu X; Tang J; Liu Z; Li M; Zhang T; Zhang X; Ding K
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5916-5919. PubMed ID: 27839917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
    Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O
    Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
    Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
    Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allylic thiocyanates as a new class of antitubercular agents.
    Silveira GP; Ferreira M; Fernandes L; Moraski GC; Cho S; Hwang C; Franzblau SG; Sá MM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6486-9. PubMed ID: 22967767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
    Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
    Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
    J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.